Download Citation
Article Source:
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
Cheng H,
Zhang L,
Cogdell DE,
Zheng H,
Schetter AJ,
et al.
(2011)
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis.
PLOS ONE 6(3): e17745.
https://doi.org/10.1371/journal.pone.0017745